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Abstract 
We have investigated the utilisation of four analogues of creatine by cytosolic Creatine Kinase (CK), using 31P-NMR in the porcine 
carotid artery, and by mitochondrial CK (Mt-CK), using oxygen consumption studies in isolated heart mitochondria and skinned fibres. 
Porcine carotid arteries were superfused for 12 h with Krebs-Henseleit buffer at 22°C, containing 11 mM glucose as substrate, and 
supplemented with either 20 mM /3-guanidinopropionic a id (/3-GPA), methyl-guanidinopropionic ac d(m-GPA), guanidinoacetic a id 
(GA) or cyclocreatine (cCr). All four analogues entered the tissue and became phosphorylated byCK as seen by 31P-NMR. Inhibition of 
oxidative metabolism by 1 mM cyanide after accumulation of the phosphorylated analogue resulted in the utilisation of PCr, /3-GPA-P, 
GA-P and GA-P over a similar time course (~ 2 h), despite very different kinetic properties of these analogues in vitro, cCr-P was 
utilised at a significantly slower rate, but was rapidly dephosphorylated in the presence of both 1 mM iodoacetate and cyanide (to inhibit 
both glycolysis and oxidative metabolism respectively). The technique of creatine stimulated respiration was used to investigate the 
phosphorylation f the analogues by Mt-CK. Isolated mitochondria were subjected to increasing [ATP], whereas kinned fibres received a
similar protocol with increasing [ADP]. There was a significant stimulation of respiration by creatine and cCr in isolated mitochondria 
(decreased K m and increased Vma x vs control), but none by GA, mGPA or fl-GPA (also in skinned fibres), indicating that these latter 
analogues were not utilised by Mt-CK. These results demonstrate differences in the phosphorylation a d dephosphorylation of creatine 
and its analogues by cytosolic CK and Mt-CK in vivo and in vitro. 
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1. Introduction 
Creatine is phosphorylated by creatine kinase (CK) to 
produce phosphocreatine (PCr). The existence of this CK 
system has been well-documented in many mammalian 
tissues, but its exact role and importance in cellular ener- 
getics are still a matter of discussion [1]. 
In tissues with high and fluctuating energy demands, 
such as muscle and brain, ATP can be replenished with 
PCr via the CK reaction. The CK system is thought to 
either buffer changes in the ATP concentration, or to 
shuttle high-energy phosphate groups from areas of ATP 
Abbreviations: CK, creatine kinase; Cr, creatine (N-methyl(glyco- 
cyamine)); PCr, phosphocreatine (N(-phosphonoamidino)sarcosine); GA, 
guanidinoacetic a id (glycocyamine); /3-GPA, fl-guanidinopropionic acid 
(N-amidino-fl-alanine); cCr, cyclocreatine (1-carboxymethyl-2-imin- 
oimidazolidine); mGPA, methyl-guanidinopropionic ac d (N,N-methyl- 
amidino-fl-alanine); Mt-CK, ubiquitous mitochondrial creatine kinase. 
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production (e.g., mitochondria) to areas of ATP consump- 
tion (e.g., contractile proteins) [1,2]. Much evidence for 
this latter hypothesis comes from the existence and subcel- 
lular localisation of CK isoenzymes [2]. 
The five isoenzymes of CK currently known to exist in 
mammalian tissues, originate from four gene products [2]. 
Three isoenzymes are found in the cytoplasm, and two in 
the mitochondria. The cytosolic isoenzymes form dimers 
from the two monomers, M (muscle type) and B (brain 
type). The MM isoenzyme is found predominantly in 
skeletal muscle and heart; BB is found in smooth muscle 
and neural tissue; and MB is found in heart, and develop- 
ing skeletal muscle. 
The two mitochondrial isoenzymes are both found in 
the intermembrane space, either free or bound to the inner 
mitochondrial membrane [3,4]. In vitro, mitochondrial CK 
(Mt-CK) has been shown to form stable dimeric and 
octameric molecules which are readily interconvertible. 
Electron microscopy has shown that the octameric forms 
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of Mt-CK display a very similar structure in all tissues so 
far studied [3], appearing cube-like, with four-fold symme- 
try and a central cavity. Octameric Mt-CK is thought o be 
the prominent form in vivo. 
Mt-CK phosphorylates creatine, and has been suggested 
to have privileged access to mitochondrial (oxidative) ATP, 
which is transported by the adenine nucleotide translocase 
(ANT). The ADP produced is transported back into the 
mitochondrial matrix via the ANT, whilst PCr passes into 
the cytoplasm. The resulting ADP can stimulate oxidative 
phosphorylation. The overall process by which the phos- 
phorylation of creatine can lead to a stimulation of oxida- 
tive phosphorylation is known as creatine-stimulated res- 
piration [5,6]. 
Attempts to assess the function and importance of the 
creatine kinase system in cellular energetics have used 
creatine analogues uch as /3-guanidinopropionic acid (/3- 
GPA) to deplete creatine and phosphocreatine in the cell 
[7-14]. /3-GPA competes with creatine for uptake into 
cells [15,16] and is a poor substrate for CK (increased 
Michaelis constant and decreased maximum velocity) [14]. 
Animals fed for 5-19 weeks on a 1% diet of/3-GPA show 
a 90% reduction of PCr in heart and skeletal muscle and 
replacement with /3-GPA-P [7,8,11-13]. Depletion of the 
creatine pool in this way, however, is associated with 
modifications (pathological or adaptive) that may be due to 
an altered energetic status in the cell [4,12,13,17]. In 
particular, a proliferation of Mt-CK was observed in /3- 
GPA fed animals which was attributed to a lowered energy 
state in the cells [10]. As /3-GPA is not a very effective 
substrate for Mt-CK [2,3], based on in vitro kinetic studies 
using purified MM CK [18], it was thought that Mt-CK 
could not act on or respond to /3-GPA due to some 
specificity of Mt-CK [4,19]. This proved to be correct, and 
it was concluded that it was the low concentration of 
substrate for Mt-CK (and not the energy state of the cell) 
that signalled Mt-CK proliferation [4,19]. The reason for 
the difference between creatine and /3-GPA was, however, 
not addressed. 
Further studies have shown that the feeding of other 
creatine analogues results in replacement of tissue PCr 
pools by synthetic phosphagens with different kinetic and 
thermodynamic properties. Consequent subtle changes in 
intracellular energy metabolism [9,20] appear to have po- 
tential therapeutic effects. In particular, cyclocreatine, 
which as a poor phosphate donor has been shown to have 
beneficial effects in cancer chemotherapy [21-24]. Simi- 
larly, the same analogue has shown anti-viral properties 
[23], delayed onset of rigor in ischaemic hearts [25] and 
protective nergetic effects in brain [26] and skeletal mus- 
cle [27]. In vitro predictions for analogue utilisation by CK 
in vivo, do not differentiate between cytosolic and Mt-CK. 
Indeed, in vitro kinetics from studies on purified MM-CK 
seem to predict very different properties to those seen in 
vivo, and this may be related to the different specificities 
of cytosolic CK compared with Mt-CK. The differential 
utilisation of creatine and its analogues in vivo by either 
cytosolic or Mt-CK has not been investigated. A possible 
difference in specificity may have relevance in explaining 
the in vivo effects of creatine analogues, and may help to 
explain potential therapeutic properties of other analogues. 
This study was undertaken to elucidate further the 
specificity of CK isoenzymes for creatine and some struc- 
tural analogues of creatine. We used the porcine carotid 
artery (containing > 95% cytosolic CK) [28] to study the 
utilisation of creatine and its analogues by cytosolic CK 
(using 31P-NMR) and rat heart mitochondria to study the 
phosphorylation of creatine and its analogues by Mt-CK 
(using oxygen consumption studies). In this way, we have 
examined and compared the specificity of Mt-CK and 
cytosolic CK and some of the structure-function relation- 
ships of creatine and its analogues. 
2. Materials and methods 
2.1. Porcine carotid arteries 
2.1.1. Tissue isolation 
Porcine carotid arteries were collected at the abattoir in 
ice-cold physiological saline solution (PSS) containing (in 
mM) 116 NaC1, 25 NaHCO3, 5.4 KC1, 5 KH2PO4, 1.2 
CaC12, 1.25 MgSO 4, and 11 glucose. The arteries were 
debrided of fat and connective tissue [29] before the 
experiments. 
2.1.2. Perfusion 
One artery was chosen and placed in a 5-mm diameter 
tube. This was superfused (at 22°C and a constant flow 
rate of 15 ml/min) with PSS containing 0.5 mM KH2PO 4 
and bubbled with 95% 02-5% CO 2. Perfusate was si- 
phoned off from just above the carotids and recirculated at 
a constant volume of 5 litres. Once inside the magnet, the 
carotids were perfused for ~ 90 rain in control media, 
then in the presence of PSS supplemented with 20 mM 
/3-GPA, GA, mGPA or cCr. 
In cyanide perfusion experiments, 1 mM cyanide was 
added to the PSS after significant phosphorylation ( > 100% 
of the PCr concentration, as determined by peak height) of 
the analogue was observed in the NMR. 
2.1.3. 31p-NMR 
The carotids were equilibrated for ~ 20 min in the 
NMR tube outside of the magnet. The tube was then 
loaded into a wide-bore (72 mm) 9.6-T vertical magnet 
using a home-built NMR probe interfaced with a Bruker 
Biospec spectrometer. The homogeneity of the magnetic 
field was optimised by shimming on the proton resonance. 
3~p-NMR spectra were acquired at 161.97 MHz, using a 
60 ° pulse width of 9 ms and an interpulse delay of 2.15 s. 
Free induction decays were Fourier transformed using 
exponential line broadening of between 10 and 20 Hz 
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depending on the analogue used (due to different chemical 
shifts of the phosphorylated analogues). A spectral width 
of 8000 Hz was used with 2048 data points. Up to 800 
FIDs were summed for each spectrum. Control spectra 
were acquired for ~ 2 h to show the tissue stability, then 
for up to 24 h with the respective xperimental buffer. 
Spectra were quantified by integration of peaks, fitted to a 
Lorentzian line shape using NMR1 software. 
2.2. Rat heart 
Na-Hepes and 0.2 mM EDTA (pH 7.2) at 4°C (isolation 
medium). The mince was incubated for 15 min with 125 
mg/ml  trypsin (Fluka) and neutralised by excess trypsin 
inhibitor (Fluka) before gentle homogenisation with a glass 
Teflon homogeniser. The homogenate was centrifuged at 
1000 X g for 10 min and the pellet discarded. The super- 
natant was centrifuged at 8000 X g for 15 min. The mito- 
chondria were resuspended in isolation medium containing 
1.0 mg/ml  fatty acid free-BSA and the centrifugation was 
repeated. 
2.2.1. Heart preparation 
Rats were sacrificed by cervical dislocation and their 
hearts rapidly removed and rinsed in cold (4°C) PSS 
buffer. These were either placed in skinning solution or 
isolation medium (see below). 
2.2.2. Isolation of mitochondria 
Rat heart mitochondria were isolated by a trypsin diges- 
tion procedure [30]. Hearts were finely minced with surgi- 
cal scissors in a solution of 0.3 M sucrose, 10 mM 
2.2.3. Fibre preparation 
Endocardial fibre bundles with a diameter of approx. 
300 mm were isolated from the left ventricle of freshly 
excised rat heart and transferred into skinning solution (S, 
see below) as described by Veksler et al. [31]. Bundles 
were incubated with intense stirring for 20 min in solution 
S containing 40 /zg /ml  saponin. Bundles were then washed 
for 10 min in respiration solution (R, see below) without 
high energy phosphates at4°C. Using saponin (40/~g/ml), 
the plasma membrane is selectively permeabilised such 
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Fig. 1. Stack plot of [31P]nuclear magnetic resonance (NMR) spectra showing the effects of 12 h perfusion with 20 mM (a) fl-guanidinopropionic acid 
(/3-GPA), (b) methyl-guanidinopropionic ac d(mGPA), (c) guanidinoacetic a id (GA) and (d) cyclocreatine (cCr) on porcine carotid artery in the presence 
of 11 mM glucose. Spectra at t = 0 are control spectra at the start of perfusions. Peak positions are as indicated. PEth, phosphoethanolamine; PChl, 
phosphocholine; PCr, phosphocreatine; mGPA-P, phosphorylated mGPA; /3-GPA-P, phosphorylated fl-GPA; GA-P, phosphorylated GA; cCr-P, 
phosphorylated cCr. 
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that the mitochondrial function can be determined for 
mitochondria that have not experienced the rigorous isola- 
tion procedure. Respiratory parameters in saponin skinned 
fibres were determined using the method described previ- 
ously for heart muscle [31]. 
2.2.4. Measurement of respiratory parameter 
The respiratory rates were determined by a Clark oxy- 
gen electrode (Hansatech) in an oxygraph containing a 
mitochondrial suspension, or 2-5 mg dry weight of fibres, 
in solution R at 30°C with continuous tirring. The solubil- 
ity of oxygen was taken to be 400 ng atoms oxygen/ml. 
Fibres or mitochondria were introduced into the oxygraph 
cell and oxygen consumption measured uring sequential 
substrate addition. Fibres were dried and weighed, with 
respiration rates expressed as ng atoms of oxygen/min/mg 
d.w. for the fibres. Mitochondria were assayed for protein 
content by the Biorad assay and results reported as ng 
atoms of oxygen/min/mg soluble protein for mito- 
cbondria. 
2.2.5. Kinetics 
ATP kinetic experiments were performed on isolated rat 
heart mitochondria. Mitochondria were introduced into the 
oxygraph cell and exposed to increasing [ATP] in the 
presence (20 mM) and absence of creatine and its ana- 
logues. The ATP stimulated respiration above basal oxy- 
gen consumption was used to determine the apparent K m 
and Vma x of the mitochondria for ATP, in the presence of 
Cr, GA, mGPA and /3-GPA. Other experiments on rat 
heart fibres were done by addition of ADP to determine 
the apparent K m and Vma x in the presence (20 mM) and 
absence of creatine and its analogues. 
2.2.6. Solutions 
Skinning solution (S) and Respiration solution R con- 
tained (mM) EGTA 10 (pCa 2÷ 7), free Mg 2÷ 3, taurine 
20, dithiothreitol 0.5, and imidazole 20 (pH 7.0). Ionic 
strength was adjusted to 0.16 M by addition of potassium 
2-(N-morpholino)ethanesulfonate. Solution S also con- 
tained 5 mM MgATP and 15 mM PCr. In place of high 
energy phosphates, olution R contained 5 mM glutamate, 
2 mM malate, 3 mM phosphate and 2 mg/ml  fatty acid 
free BSA [4]. 
2.2.7. Materials 
/3-GPA, cyclocreatine and mGPA were synthesised in 
the laboratory using the methods of Rowley et al. [18]. 
Purity was checked by 1H-NMR. Raw materials were 
purchased from Apin Chemicals Ltd. 
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Fig. 2. Stack plot of 31P-NMR showing the effect of 1 mM cyanide on porcine carotid arteries, after accumulation (at t = 0) of greater than 1:1, PCr: (a) 
fl-GPA-P, (b) mGPA-P, (c) GA-P and (d) cCr-P, in the presence of 1 1 mM glucose. PCr, fl-GPA-P, mGPA-P and GA-P are all utilised within 2 h, 
whereas cCr-P persists. Abbreviations are as in Fig. 1. 
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2.2.8. Statistics 
The test for significance was the Student's t-test. Re- 
sults are reported as standard error of the mean. 
3. Results 
3.1. NMR 
3.1.1. Phosphorylation 
Fig. 1 shows 31p-NMR spectra from porcine carotid 
arteries perfused with 20 mM (a) /3-GPA, (b) mGPA, (c) 
GA, or (d) cCr. Perfusion with each analogue led to the 
appearance of the phosphorylated analogue after a similar 
lag period of ~ 2-3 h (not shown), with a significant 
accumulation (> [PCr]) of the phosphorylated analogue 
after 12 h in all groups. The resonances for the phospho- 
rylated analogues are (ppm): /3-GPA, -0.44;  GA, -0.48;  
cCr, + 0.15; mGPA, co-resonant with phosphocreatine. 
The accumulation of each phosphorylated analogue was 
not significantly different after 12 h (n > 3), as determined 
from the respective peak areas. 
3.1.2. Dephosphorylation 
In a separate set of experiments, 1 mM cyanide was 
added to the perfusion buffer when the P-analogue: PCr 
ratio was ~ 1:1 (determined for mGPA when the com- 
bined mGPA/PCr  peak was greater than twice the PCr 
peak at t = 0). The effects of cyanide on both PCr and 
phosphorylated analogue is shown in Fig. 2. In the pres- 
ence of cyanide the PCr, GA-P,/3-GPA-P and mGPA/PCr 
peaks disappear after about 2 h. with a concomitant in- 
crease in intracellular phosphate. In contrast, cCr-P is still 
present in significant amounts after 6 h (Fig. 2d). 
Fig. 3 shows the effects of adding 1 mM iodoacetate 
(IAA) to the perfusion buffer containing cCr after 6 h 
perfusion with cyanide. IAA inhibits sulfydryl group con- 
taining enzymes, and in particular, glyceraldehyde-3-phos- 
phate dehydrogenase. It is therefore a non-specific in- 
hibitor of glycolysis. After about 40 min, both ATP and 
cCr-P begin to decrease in parallel. There is a concomitant 
increase in the intracellular phosphate peak, and phospho- 
monoester peaks, possibly due to an accumulation of gly- 
colytic intermediates such as glyceraldehyde phosphate. 
By 2 h, ATP and cCr-P are indistinguishable from the 
noise. 
3.2. Rat heart 
3.2.1. Isolated mitochondria 
Using sequential additions of ATP, respiration is sup- 
ported by ADP produced by the MgATPase reaction(s) in 
the mitochondria. The kinetic parameters given charac- 
terise this reaction (Table 1, control values). In the pres- 
ence of creatine, as the reaction catalysed by Mt-CK is the 
dominant source of ADP, the Vma x in the presence of ATP 
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Fig. 3. Stack plot of  3t P -NMR showing the effect 1 mM iodoacetate 
(IAA). Spectrum at t = 0 is the spectrum from perfusion with 20 mM 
cyclocreatine (cCr) for 12 h (Fig. ld) fol lowed by perfusion with 1 mM 
cyanide for 6 h (Fig. 2d). Perfusion with IAA leads to the loss of  both 
cCr-P and ATP after 2 h, with the concomitant increase in intracellular 
phosphate (Pi(i,)) and phosphomonoesters (e.g., Glyceraldehyde-6-phos- 
phate and other glycolytic intermediates). Abbreviations are as in Fig. 1. 
is increased. An increased Vma x associated with a de- 
creased K m (indicating an effective coupling of the CK 
reaction to oxidative metabolism [5]) is termed creatine- 
stimulated respiration [6,30,39]. 
Due to an increased Vma x, and decreased Km,  in the 
presence of cCr, it was concluded that cCr was phospho- 
rylated by Mt-CK. The increase in Vma x was less than that 
seen in the presence of creatine, but the K m was decreased 
to a greater extent (Table 1). 
Neither GA, /3-GPA [4], or m-GPA had any significant 
effect on the mitochondrial response to ATP compared 
with control. We conclude that there was no GA-, /3-GPA-, 
or m-GPA-stimulated respiration and that Mt-CK was 
unable to phosphorylate hese analogues under these condi- 
tions. 
Table 1 
Respiration in isolated mitochondria 
Substrate CSR Vm, x K m n 
(ng atoms O mg ( ~M ATP) 
prote in-  i m in -  l ) 
None b - 273+ 16 46 .9+3.6  10 
Creatine + + + 473 + 44 " 24.8 + 2.9 a 9 
cCr + 363+35 a 18 .0+ 1.6 a 15 
GA - - - 4 
/3-GPA b - 3195:4  60.3_+5.5 10 
mGPA - - - 4 
+ Standard error of  the mean. 
" Signif icantly different from control (P  < 0.05). 
CSR-creatine stimulated respiration (relative stimulation). 
b [4]. 
124 E.A. Boehm et al. / Biochimica et Biophysica Acta 1274 (1996) 119-128 
3.2.2. Fibres 
When the analogue appeared to be unable to stimulate 
respiration, experiments were repeated with saponin-per- 
meabilised myocardial fibres, with creatine-stimulated-res- 
piration observed as a decrease in apparent K m for ADP 
[4,5]. There were no significant differences in the respira- 
tory responses in the presence of GA, /3-GPA [4], or 
m-GPA (data not shown). We conclude that Mt-CK is 
unable to act on or respond to these analogues. 
4. Discussion 
We have demonstrated previously that the creatine ana- 
logue /3-GPA is phosphorylated by creatine kinase in the 
perfused porcine carotid artery [29]. It was concluded that 
fl-GPA was phosphorylated by cytosolic isoforms of CK 
because /3-GPA was not phosphorylated by Mt-CK [4,19]. 
Cr and /3-GPA are structural isomers. Cr is methylated on 
its tertiary nitrogen (Fig. 4a), whilst in /3-GPA, the methyl 
group is positioned in the carbon chain (Fig. 4d). There are 
two possible reasons why /3-GPA is not phosphorylated by
Mt-CK. Either the methyl group is important in the active 
site, or the carbon chain in the /3-GPA molecule is too 
long to fit in the active site. The aim of this study was to 
investigate the utilisation and specificity of /3-GPA and 
three other analogues of creatine by both cytosolic and 
Mt-CK, by their ability to be phosphorylated and dephos- 
phorylated. 
4.1. Cytosolic CK  
4.1.1. Phosphorylation 
The creatine analogues GA, /3-GPA, m-GPA and cCr 
are all phosphorylated by creatine kinase in the porcine 
carotid artery, as evidenced by the appearance of NMR 
peaks co-resonant with, or in the vicinity of the PCr peak 
(Fig. 1). The accumulation of each phosphorylated ana- 
logue after 12 h was not significantly different, as deter- 
mined by measuring peak areas. This is interesting when 
one considers the different reactivities of these analogues 
in vitro. Due to the high percentage of cytosolic CK in the 
porcine carotid artery (> 95%) [28], we assume that a 
large proportion of the creatine analogue is phosphorylated 
by cytosolic CK in vivo. Reactivity measured in vitro with 
rabbit muscle MM CK occurs in the order (number of fold 
less reactive than Cr): cCr, (30); GA, (100); mGPA, (500); 
and /3-GPA (1500) [32]. This selectivity of CK might be 
explained by studying the structures of the analogues. Two 
main structural parameters investigated are the carbon 
chain length, and the geometry created by the methyl 
group on the tertiary nitrogen. NMR studies of cCr and 
cCr-P have shown that the primary amino group of this 
compound is phosphorylated. This result and others, 
strongly imply that creatine is phosphorylated on the 
guanidino nitrogen that is trans to the methyl group when 
it is bound to the enzymes surface [18]. This N-methyl 
group, which is considered an important structural feature 
for the CK reaction, as Cr is 100 times more reactive than 
GA itself, has been proposed to cause a favourable confor- 
mational change of the enzyme to occur at the active site 
[33]. The carbon chain length is also important as seen by 
the difference in reactivity measured in vitro between Cr 
and mGPA (Fig. 4a,b), and GA and /3-GPA (Fig. 4c,d) 
[18,32]. Interestingly, cyclocreatine, and homocyclocrea- 
tine, which differ by a methylene group in the same way as 
creatine and mGPA, differ in reactivity to a similar extent 
[32]. Our studies have demonstrated that this order of 
reactivity is not apparent in vivo, most probably because 
the range of reactivities of the creatine analogues (30- to 
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Fig. 4. Structures of(a) creatine (Cr), (b) methyl-guanidinopropionic acid (mGPA), (c) guanidinoacetic acid (GA), (d) ~-guanidinopropionic acid(,8-GPA) 
and (e) cyclocreatine (cCr), showing the relative site of phosphorylation. 
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1500-fold less reactive than creatine) are similar to the rate 
of the CK flux compared with the ATPase flux [34,35]. 
Interestingly, perfusion with Cr for 12 h leads to an 
increase in PCr that is similar in magnitude to the increase 
seen with perfusion with mGPA [36] i.e. even Cr as the 
most reactive substrate for CK still does not appear to be 
phosphorylated more effectively in vivo in the porcine 
carotid artery than any of the analogues studied, as seen by 
NMR. It is assumed that at a perfusion concentration of 20 
mM, creatine and its analogues are flooding across the 
membrane, and that phosphorylation is not transport- 
limited. 
4.1.2. Dephosphorylation 
To investigate the effectiveness of the phosphorylated 
analogue as a substrate for CK, we added cyanide to the 
'analogue loaded tissue' in order to inhibit oxidative 
metabolism. Oxidative metabolism in smooth muscle has 
been linked to PCr production, which has been shown to 
be important for contractile function [37,38]. In the unstim- 
ulated resting smooth muscle preparations used here, the 
function of PCr, and indeed oxidative metabolism is not 
clear. The low basal oxygen consumption i resting porcine 
carotid artery 002 of 0.069 p, mol g wet wt.- l  min- l )  
[40] predicts a low turnover of ATP. It can be postulated 
then, that in our preparations, a resultant low flux through 
the CK reaction leads to a small rate of production of PCr. 
We and others have shown that inhibition of oxidative 
metabolism with cyanide or hypoxia leads to a loss of PCr 
as seen by NMR, but only to a small decrease in ATP 
[29,41,42]. The contribution of glycolysis to vascular 
smooth muscle metabolism can be calculated under anaer- 
obic conditions (such as in the presence of cyanide), to 
produce up to 70% of the resting tissue [ATP] [40]. This 
explains why [ATP] can be maintained under anaerobic 
conditions, and with the loss of PCr supports compartmen- 
tation of metabolites. The fact that fl-GPA is poorly 
phosphorylated in the presence of cyanide (but with a 
maintained [ATP]), also predicts some compartmentation 
of metabolites in this tissue [29]. 
In the presence of the phosphorylated analogue, cyanide 
leads to the loss of GA-P, fl-GPA-P and m-GPA-P within 
2 h (Fig. 2a-c). No significant difference was seen in the 
rate of breakdown of fl-GPA-P (the least reactive analogue 
in vitro) compared with the rate of breakdown of PCr (Fig. 
5). This is surprising as fl-GPA-P is a poor substrate for 
CK in vitro, with approx. 1/1500th the reactivity of 
phosphocreatine [14]. As discussed above, the CK reaction 
in vivo, is two-to-three orders of magnitude faster than the 
ATPase activity [34,35], so that using this criterion, a poor 
substrate for CK in vitro can again be used by CK in vivo. 
cCr-P is dephosphorylated over a much slower time 
course than GA-P, /3-GPA-P and mGPA-P, decreasing by 
< 50% after 6 h (Fig. 2d). This difference is reflected in 
the kinetics of cytosolic CK measured for cCr. Table 2a 
gives literature values of the K m and Vma x (of cytosolic 
CK) for Cr, /3-GPA and cCr in both phosphorylated and 
unphosphorylated forms. Although not a definitive term, 
we may assume that the value given by Vmax//Km for an 
enzymatic reaction is the propensity for that reaction to 
proceed in a particular direction. The values calculated for 
the phosphorylated and unphosphorylated analogues how 
that both Cr and /3-GPA are more likely to be dephospho- 
rylated (as seen by the difference in Vmax/K  m for the 
forward and reverse reaction, i.e., Yp/Y.p > 10 (Table 2a), 
whereas the values calculated for cCr and cCr-P imply that 
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Fig. 5. Graph showing rate of decrease of PCr and ~8-GPA-P in the porcine carotid artery after addition of 1 mM cyanide. Metabolite concentration is
represented as the peak area relative to the peak area at t = 0 (the point of cyanide addition). 
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Table 2 
Kinetic data from (a) cytosolic and (b) mitochondrial creatine kinase 
Substrate Vma x K m Vma x / /K  m Yp/Y_p 
(cytosolic CK) (/zM/min/ (raM) (Y) 
/mgCK) 
(a) 
Cr a 75.1 16.7 4.5 
PCr ~ 231 2.2 105 23.3 
fl-GPA a 0.21 50 0.0042 
/3-GPA-P ~ 0.22 4.9 0.045 10.7 
cCr b 1.88 55 0.62 
cCr-P b 33.9 3.7 0.50 0.8 
(b) 
Substrate Vma x (/xM/ K m Vma x /K  m 
(Mt-CK) min/mgCK) (mM) (Y) 
Yp/Y-p 
Cr c 15 8.0 1.88 
PCr c 45 3.0 15.0 7.9 
[14] 
b [43] 
c [471. 
Yp/Y_p; ratio of Vrnax/K m (phosphorylated form):Vma x / Km(unphos- 
phorylated form). 
the reaction has no real preference to proceed in either 
direction (Yp/Y_p < 1). Utilisation of cCr-P is subject to 
kinetic constraints which derived from the fact that its 
Gibbs energy of hydrolysis is 8.4 k J /mol  lower than that 
of PCr. Comparison of Vmax/K m ratios for cCr-CK equi- 
librium and Cr-CK equilibrium, obtained in vitro with 
purified MM CK have indicated that Cr is approximately a 
6- to 7-fold better substrate for CK than cCr (McLaughlin 
et al. [43]) at 37°C, whereas PCr is a 200-fold better 
substrate than cCr-P (Table 2) [14,44]. The relative inabil- 
ity of CK to utilise cCr-P is demonstrated in its slow 
utilisation in the presence of cyanide (seen in Fig. 2d). 
As the high glycolytic capacity of smooth muscle can 
maintain ATP in the absence of oxidative ATP, then the 
CK reaction appears to follow the prediction made by 
solution kinetics (Vmax/Km) (Table 2). To determine if 
cCr-P can be utilised by CK, we used IAA in the presence 
of cyanide to inhibit glycolysis as well as oxidative 
metabolism to create a situation where ATP is rapidly 
falling. Under these conditions, cCr-P and ATP both de- 
creased at similar rates, indicating that cCr-P can indeed be 
utilised by CK (Fig. 3). This is in agreement with work in 
chronically fed animals which have shown the utilisation 
of cCr-P under conditions of ATP depletion [20,26,27,45- 
47]. 
PCr, /3-GPA-P, GA-P and m-GPA-P all act similarly in 
the presence of cyanide; cCr-P behaves differently, how- 
ever, which can be explained by studying its structure and 
kinetics, cCr is the only analogue studied which has a 
greater propensity to exist in its phosphorylated form in 
the presence of CK, as shown by in vitro kinetics and 
confirmed here by NMR. The difference can be attributed 
to its planar 5-membered ring structure (Fig. le) [18]. 
Although cCr is a relatively good substrate for CK in vitro, 
the puckered 6-membered ring structure of 1-carbo- 
xymethyl-2-iminohexahydropyrimidine (with an extra 
-CH 2 in the ring) is over 400 times less reactive [18]. This 
and other measurements indicate a very low affinity by the 
active site of CK for substituents which project from the 
plane defined by the three guanidino nitrogen atoms and 
suggests that portions of the active site are only accessible 
to relatively flat, and compact structures. It is likely that 
phosphorylation of cyclocreatine results in a planar-to- 
puckered transformation, which is reflected in Vmax/K m 
values (Table 2) [18]. Other work has shown that as these 
values would predict (in analogue fed animals), cCr-P can 
accumulate to high concentrations in the cell, due to the 
relative low reactivity of the phosphorylated form [20,47]. 
Although in vitro kinetic data on cytosolic CK predicts 
otherwise, in vivo feeding studies have shown that many 
analogues of CK can serve as potential substitutes for 
creatine. Our acute studies here have confirmed this, show- 
ing that even the poorest substrate studied, /3-GPA//3- 
GPA-P, can be readily utilised in a living tissue containing 
> 95% cytosolic CK. Indeed, it was dephosphorylated 
with a rate similar to PCr, when the kinetics would predict 
a 1500-fold difference in rate, implying that dephospho- 
rylation is determined by the ATPase rate and not CK. 
However, acute studies with cCr have shown that the 
predicted properties in vitro can correspond to what is seen 
in vivo. Care must therefore be taken if one wishes to 
predict in vivo kinetics using in vitro data. It is likely that 
the kinetic properties of cCr have relevance to this ana- 
logue's potential therapeutic properties. In cells with a 
high metabolic turnover, feeding creatine or an analogue 
might be expected to lead to a high rate of utilisation. The 
kinetic properties of cCr, however, would lead to a high 
rate of phosphorylation, but a low rate of dephosphoryla- 
tion. Cyclocreatine might thus act as a phosphate sink, 
leading to the eventual depletion of ATP, and the corre- 
sponding inhibition of tumour growth [21]. Similarly, the 
fact that cCr-P can act as a store of high-energy phosphate, 
that is only utilised in times of rapid ATP depletion, may 
explain the potential beneficial effects of cCr during is- 
chaemia. 
4.2. Mitochondrial CK 
In vitro studies using MM CK assume that there is only 
one form of CK that is responsible for phosphorylating 
creatine and its analogues. Studies have shown that oc- 
tameric Mt-CK appears to have a central cavity which 
might be the active site [3]. Perhaps this active site, which 
is more hidden than the corresponding active site in the 
cytosolic isoenzymes, has a higher structural specificity 
and may be a partial explanation for the apparent greater 
specificity of Mt-CK compared with cytosolic CK. 
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4.2.1. Creatine-stimulated r spiration 
The function of Mt-CK is to phosphorylate Cr, with the 
subsequent release of PCr into the cytosol [5]. This reac- 
tion proceeds preferentially in the direction of PCr synthe- 
sis. Phosphorylation of Cr by Mt-CK is seen by a stimula- 
tion of respiration due to the production of ADP in the 
intermembrane space [4]. The mechanism for creatine 
stimulated respiration occurs when Mt-CK is functionally 
coupled to oxidative phosphorylation. ADP is produced 
and enters the mitochondrial matrix via the adenine nu- 
cleotide translocase (ANT) and stimulates oxidative phos- 
phorylation [5,6,48]. We examined the respiratory re- 
sponses of the mitochondria, nd found that Mt-CK could 
not use exogenous ATP to phosphorylate GA or /3-GPA, 
whilst it could phosphorylate cCr and creatine. It is not 
thought hat creatine differs from its analogues in terms of 
its accessibility to Mt-CK, as porin, the transport protein in 
the outer mitochondrial membrane is permeable to most 
small molecules. Both Cr and cCr share some common 
structural features, in that they are both compact molecules, 
with a similar geometry about the tertiary nitrogen. It was 
intriguing that GA could not be phosphorylated by Mt-CK, 
and pointed to the importance of the methyl group in its 
mechanism of action. As both /3-GPA and GA are not 
phosphorylated by Mt-CK [4,19], it was therefore interest- 
ing to establish whether it was solely the lack of the 
methyl group that was important here, or rather the carbon 
chain length that also placed some constraint on the speci- 
ficity of Mt-CK. mGPA was not phosphorylated, indicat- 
ing that both the methyl group and carbon chain length are 
important. There appears then to be a greater specificity 
for Mt-CK compared with cytosolic CK, in terms of both 
substrate size and geometry. 
These results imply a more tightly constrained active 
site for Mt-CK, compared with cytosolic CK. The kinetic 
parameters of purified octameric Mt-CK for its substrates 
are shown in Table 2b [49] and are qualitatively similar to 
those seen for cytosolic CK. The difference, therefore, in 
both the structure and specificity of Mt-CK might be 
related to its coupling to the ANT which effects the 
kinetics so that Mt-CK phosphorylates Cr using mitochon- 
drially generated ATP, with the ADP generated being 
taken up preferentially by the ANT [50]. The octameric 
structure of Mt-CK might be a requirement for its associa- 
tion with the ANT; an indirect result of this may be that 
the active site of Mt-CK is more specific than its cytosolic 
counterpart, although of course, Mt-CK and cytosolic CK 
are different enzymes. 
The fact that cCr is utilised by Mt-CK may have 
benefits in its therapeutic effects in that administering cCr 
may not lead to the pathologic adaptations that are seen in 
the feeding of other analogues. As has been discussed, 
feeding fl-GPA feeding leads to the development of 
paracrystalline occlusions, as well as other energetic modi- 
fications, which would be expected to be minimised with 
cCr feeding. 
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